View Single Post
Old 05-20-2014, 05:38 PM
Conductor71's Avatar
Conductor71 Conductor71 is offline
Senior Member
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
15 yr Member
Conductor71 Conductor71 is offline
Senior Member
Conductor71's Avatar
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
15 yr Member
Default Abbvie still enrolling for Duodopa study

I was quite surprised to learn this given that they have applied for FDA review, but they are indeed still enrolling for phase 3 open label trials. The kicker is that the limit is for 38 participants and takes place in only a few states: CA, WA, IL, MI.

I am fortunate enough to have a study going on less than 50 miles from my home. I already have a tentative date of July 2nd for the procedure.


I know that some are skeptical, but I think this might be a really great opportunity for a less invasive surgery than DBS. There are many benefits:

proven therapy that works (efficacy in high 90th percentile)
longitudinal evidence it is relatively safe
benefit of 16 hours continuous "on time"
less dyskinesia
minimally invasive 45 min. procedure (home in 2 hours local anesthetic only)
free ride on expensive drug for a minimum of 15 months

I already have the procedure tentatively scheduled for July 2nd! I go in for my first screening appt in early June.

I hope I make the cut. If there is interest I will share more info if it looks like it is all systems go for me.

Laura

link to study info: https://www.clinicalconnection.com/19726.aspx
Conductor71 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Jim091866 (06-25-2014), johnt (05-21-2014), Lemonlime (05-21-2014), Tupelo3 (05-20-2014)